GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » 5-Year EBITDA Growth Rate

Enwei Pharmaceutical Co (SZSE:301331) 5-Year EBITDA Growth Rate : -8.60% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enwei Pharmaceutical Co 5-Year EBITDA Growth Rate?

Enwei Pharmaceutical Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.04.

During the past 12 months, Enwei Pharmaceutical Co's average EBITDA Per Share Growth Rate was -50.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -15.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Enwei Pharmaceutical Co was 6.00% per year. The lowest was -15.40% per year. And the median was -5.60% per year.


Competitive Comparison of Enwei Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Enwei Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enwei Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enwei Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Enwei Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.



Enwei Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Enwei Pharmaceutical Co  (SZSE:301331) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Enwei Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Enwei Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Enwei Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.
Executives
Zhuang Yan Directors; Executives
Chen Lei Executives
Hu Da Wei Executives; Directors and Secretaries

Enwei Pharmaceutical Co Headlines

No Headlines